BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38474106)

  • 1. Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors.
    Dibdiakova K; Majercikova Z; Galanda T; Richterova R; Kolarovszki B; Racay P; Hatok J
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
    Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
    Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
    Kachra Z; Beaulieu E; Delbecchi L; Mousseau N; Berthelet F; Moumdjian R; Del Maestro R; Béliveau R
    Clin Exp Metastasis; 1999; 17(7):555-66. PubMed ID: 10845554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
    Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
    J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
    Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
    Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows.
    Grzesiak M; Kaminska K; Knapczyk-Stwora K; Hrabia A
    Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.
    Pagenstecher A; Wussler EM; Opdenakker G; Volk B; Campbell IL
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):598-612. PubMed ID: 11398836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
    Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
    Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture.
    Fortunato SJ; Menon R; Lombardi SJ
    J Perinat Med; 1999; 27(5):362-8. PubMed ID: 10642956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.
    Mohanam S; Wang SW; Rayford A; Yamamoto M; Sawaya R; Nakajima M; Liotta LA; Nicolson GL; Stetler-Stevenson WG; Rao JS
    Clin Exp Metastasis; 1995 Jan; 13(1):57-62. PubMed ID: 7820957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
    PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
    Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
    J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.
    Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I
    Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
    Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Tumor Necrosis Factor Alpha on the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Keratoconus Fibroblasts].
    Feng P; Li X; Chen W; He R; Wang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Dec; 33(6):1139-44. PubMed ID: 29714979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
    Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
    Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.